We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Operational Update

6 Oct 2014 07:00

RNS Number : 4734T
Phorm Corporation Limited
06 October 2014
 

6 October 2014

 

Phorm Corporation Limited

("Phorm" or the "Company")

Operational Update

 

Phorm (AIM: PHRM), a leading internet personalisation technology company, announces an unaudited operational and financial update demonstrating continued robust growth in the group's revenues and key performance indicators (KPIs), since its previous update, announced on 27 June 2014.

 

Key Performance Indicator

H1 20136 months

H2 20136 months

H1 20146 months

Q3 2014*3 months

Peak Daily Unique Users (m)

0.8

14.1

37.8

73.5

Total Advertising requests (bn)

1.6

22.3

72.9

78.3

Total Advertisements served (bn)

0.1

0.8

2.6

3.3

Total Revenues (US$'000s)

28.5

251.3

528.8

474.0

 

Note:

* KPIs for Q3 2014 are for the 3-month period from 1 July 2014 to 30 September 2014.

 

On 22 August 2014, Phorm announced in its unaudited interim results for the six months ended 30 June 2014 that the Company's technology was deployed with 10 internet service providers ("ISPs") worldwide; this has now increased to 16 ISPs. As a result, the number of users has grown significantly. The number of peak daily unique users in Q3 2014 versus H1 2014 has grown from 37.8m to 73.5m.

 

The number of advertising requests received from website publishers has also increased significantly. In Q3 2014, the Company exceeded the total number of advertising requests received in the whole of H1 2014, with 78.3 billion requests received. This is a reflection of both the increase in the number of users and the number of publishers and advertising exchanges with whom the Company is working.

 

On 27 June 2014, Phorm announced that it expected the growth in the number of advertisements served to strengthen with the gathering momentum of its operations in China and elsewhere. The Company is pleased to announce that this growth is now evident in its results. The total number of advertisements served in the 3 month period to 30 September 2014 was 3.3 billion, which compares favourably with the 2.6 billion served in the previous 6 months.

 

The increase in the number of advertisements served reflects the growth of new advertising relationships in China and elsewhere. The speed with which test campaigns are converting into revenue generating commercial campaigns is also increasing. The Company has already generated US$474,000 in gross revenue in the 3 month period to 30 September 2014 and over the course of the last few weeks it has seen the rate of revenue generation increase significantly.

 

The Company is continuing to focus on the acceleration of revenue growth while maintaining the high standards of advertising performance that have been achieved to date and will provide further updates in due course.

-Ends-

For further information please contact:

Phorm Corporation Limited

Andy Croxson (analysts and investors) +44 20 3397 6001

UK Investors

Mirabaud Securities LLP (Broker) +44 20 7321 2508

Jason Woollard

Peter Krens

Strand Hanson Limited (Nominated Adviser) +44 20 7409 3494

James Harris

Matthew Chandler

James Dance

US Investors

Lippert/Heilshorn and Associates (Investor Relations) +1 212 838 3777

John Heilshorn

 

 

About Phorm

 

Phorm is a global personalisation technology company that makes content and advertising more relevant to the consumer. Phorm's innovative platform preserves user privacy and delivers a more interesting online experience.

 

Phorm's industry leading technology enables its ISP partners to offer a new type of online advertising platform and a free consumer internet content feature, ensuring more relevant advertisements and personalised content for opted-in users.

 

Phorm's advertising platform revolutionises current standards of online privacy, fully protecting the identity of consumers. Phorm's solution is completely opt-in. Only those users consenting to the service are profiled and only ever on an anonymous basis.

 

Phorm's partners include leading ISPs, Publishers, Advertising Networks and Advertisers.

 

Phorm, under a predecessor holding company, was admitted to the AIM market of the London Stock Exchange in 2004.

 

For more information, please visit: www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCFELLBZBFXFBL
Date   Source Headline
5th Jan 20107:00 amRNSTransfer of shares
17th Dec 200911:51 amRNSPurchase of Shares and Total Voting Rights
4th Nov 20092:18 pmRNSNotification of major interest in shares
2nd Nov 200912:42 pmRNSResult of AGM
6th Oct 20092:07 pmRNSNotice of AGM
2nd Oct 20097:00 amRNSNotification of major interest in shares
21st Sep 20097:00 amRNSInterim results
14th Sep 20098:57 amRNSNotification of Results
5th Aug 20097:00 amRNSTransfer of Shares
8th Jul 20098:27 amRNSOperational Update
6th Jul 20099:22 amRNSStatement on UK operations
30th Jun 20097:13 amRNSAnnual Accounts
19th Jun 200911:06 amRNSTotal Voting Rights
18th Jun 20097:00 amRNSFinal Results
10th Jun 20097:00 amRNSPlacing to raise ?15 million
3rd Jun 200911:00 amRNSPhorm announces Webwise Discover
21st May 20097:00 amRNSKorean Market Trial
27th Apr 200910:31 amRNSStatement re Apology from "New Media Age" Magazine
14th Apr 20096:23 pmRNSPhorm Statement re EU Commission
9th Apr 20093:57 pmRNSAIM Block Admission
30th Mar 20097:00 amRNSKorean Market Trial
26th Mar 20097:03 amRNSGrant of Options
19th Mar 20091:31 pmRNSGrant of Options
18th Mar 20097:00 amRNSChange of Broker
13th Mar 20095:03 pmRNSShare Issue - Replacement
13th Mar 20092:46 pmRNSShare Issue
11th Mar 20099:49 amRNSAnnouncement of Appointments
4th Mar 20093:18 pmRNSCity Events Wire
17th Dec 20085:52 pmRNSManagement Appointments
15th Dec 20087:00 amRNSBT Trial Update
1st Dec 20087:00 amRNSPhorm Announces Board Changes
5th Nov 20087:46 amRNSDisclosure of Share Sale
22nd Oct 20085:14 pmRNSGrant of options
14th Oct 200810:15 amRNSCancellation of admission of shares
30th Sep 20087:00 amRNSInterim Results
29th Sep 20087:00 amRNSCommencement of BT Trial
22nd Sep 200811:15 amRNSResponse to Statement by BERR
4th Sep 20087:00 amRNSPhorm Update
18th Aug 20087:00 amRNSAppointment of Independent Bo
24th Jun 20087:00 amRNSTransfer of Shares
14th May 20084:45 pmRNSExercise of Options
14th May 200812:55 pmRNSAnnual Report and Accounts
10th Apr 20087:01 amRNSFinal Results
4th Apr 20084:23 pmRNSNotification of Holding
4th Apr 20084:16 pmRNSNotification Of Shareholding
4th Apr 200812:11 pmRNSNotification Of Shareholding
19th Mar 20087:01 amRNSIssue of Equity
13th Mar 200811:32 amRNSResult of Stockholder Meeting
11th Mar 20087:02 amRNSRe Share Price Movement
28th Feb 20085:50 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.